Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-cell suicide gene therapy after haploidentical SCT
NCT01204502Phase 2Terminated
- Sponsor
- Great Ormond Street Hospital
- Start
- Jan 2011
- Primary completion
- Jan 2013
- Countries
- 1
01
Overview
A Phase 2 trial of HSV-Tk engineered donor lymphocytes in primary immunodeficiency (PI), haematological malignancy, metabolic disorder, sponsored by Great Ormond Street Hospital. Started Jan 2011; status: terminated.
02
Drugs
HSV-Tk engineered donor lymphocytes
03
Conditions
primary immunodeficiency (PI)haematological malignancymetabolic disorder
Beyond the preview
Go deeper on NCT01204502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204502.